Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Chan

Showing results (281-290 of 302) with videos related to

Pageof 31
Sort By:
Nature Communications|September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney diseaseKevin Yau, Alexandra Kurtesi, Freda Qi, et al.
Hypertension (Dallas, Tex. : 1979)|September 10, 2015
Obligatory Role for B Cells in the Development of Angiotensin II-Dependent HypertensionChristopher T Chan, Christopher G Sobey, Maggie Lieu, et al.
Cardiovascular Research|October 26, 2018
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertensionShalini M Krishnan, Yeong H Ling, Brooke M Huuskes, et al.
Nature|February 1, 2019
Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular diseaseShun He, Florian Kahles, Sara Rattik, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysisKevin Yau, Christopher T Chan, Kento T Abe, et al.
JAMA Network Open|September 2, 2021
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing HemodialysisKevin Yau, Kento T Abe, David Naimark, et al.
Journal of the American Society of Nephrology : JASN|February 25, 2012
Intensive hemodialysis associates with improved survival compared with conventional hemodialysisGihad E Nesrallah, Robert M Lindsay, Meaghan S Cuerden, et al.
Cancer|January 9, 2020
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMsAaron R Hansen, Kari Ala-Leppilampi, Chris McKillop, et al.
Nature|February 15, 2019
Sleep modulates haematopoiesis and protects against atherosclerosisCameron S McAlpine, Máté G Kiss, Sara Rattik, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
Pageof 31

Showing results (281-290 of 302) with videos related to

Sort By:
Pageof 31
Nature Communications|September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney diseaseKevin Yau, Alexandra Kurtesi, Freda Qi, et al.
Hypertension (Dallas, Tex. : 1979)|September 10, 2015
Obligatory Role for B Cells in the Development of Angiotensin II-Dependent HypertensionChristopher T Chan, Christopher G Sobey, Maggie Lieu, et al.
Cardiovascular Research|October 26, 2018
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertensionShalini M Krishnan, Yeong H Ling, Brooke M Huuskes, et al.
Nature|February 1, 2019
Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular diseaseShun He, Florian Kahles, Sara Rattik, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysisKevin Yau, Christopher T Chan, Kento T Abe, et al.
JAMA Network Open|September 2, 2021
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing HemodialysisKevin Yau, Kento T Abe, David Naimark, et al.
Journal of the American Society of Nephrology : JASN|February 25, 2012
Intensive hemodialysis associates with improved survival compared with conventional hemodialysisGihad E Nesrallah, Robert M Lindsay, Meaghan S Cuerden, et al.
Cancer|January 9, 2020
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMsAaron R Hansen, Kari Ala-Leppilampi, Chris McKillop, et al.
Nature|February 15, 2019
Sleep modulates haematopoiesis and protects against atherosclerosisCameron S McAlpine, Máté G Kiss, Sara Rattik, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
Pageof 31